The treatment options are complex and varied. The specific treatment plan may
be highly individualized and can include Total Parental Nutrition (TPN) support,
which involves use of oral rehydration solutions, parenteral nutrition and enteral
nutrition. Gattex (Teduglutide) is currently the first non-surgical treatment for
short bowel syndrome (SBS), which is predicted to improve the daily, lives of the
patients and is the third approved therapy by USFDA
Click Here To Check Complete Report